Page not found

• 
• 
• 
• 

Search results

1. Nashville Biosciences and Illumina announce agreement to establish preeminent clinico-genomic resource for life sciences research & development

   ... announced an agreement with  Illumina , a leading genomic technology company, to realize the full potential of VUMC’s DNA databank, ... methods for diagnosing, preventing and treating an array of human diseases. Under the terms of the agreement, Nashville Biosciences and ...

   sommers - 01/11/2022 - 11:06am

2. Applications now open for ASPIRE postdoctoral research fellowship to support path to entrepreneurship

   ... structured training opportunity to learn how to transform a technology into a company A biomedical sciences postdoc will be hired to ... to develop a commercialization strategy on a particular technology while immersing themselves in the local bioscience entrepreneurial ...

   sommers - 02/07/2024 - 10:47am

3. Novel anti-platelet therapy for treatment of thrombosis, cardiovascular disease, and cerebrovascular injury

   Technology Description Cardiovascular disease remains one of the ... with a risk for embolism. Protease-activated receptors 1 and 4 (PAR1, PAR4) are found on human platelets and mediate normal clot formation. They are also involved in ...

   cttc_admin - 01/23/2024 - 1:42pm

4. Study shows new COVID target could improve vaccines

   ... concluded in a paper published last week in the journal  Cell . “Our team found a new site of vulnerability on the virus spike protein that can be targeted by protective human antibodies. This gives new insights into how our vaccines are working,” ...

   sommers - 04/12/2021 - 10:52am

5. Ph.D. to CEO: Entrepreneurial Transformation with the ASPIRE to Innovate Postdoctoral Fellowship Program

   ... ASPIRE Program , and Vanderbilt’s  Center for Technology Transfer and Commercialization will be supporting a biomedical ... research training as a graduate student in the Department of Cell and Developmental Biology. During her research training, she was actively ...

   sommers - 07/28/2021 - 10:05am

6. CTTC commercialized 25 COVID-19-related discoveries, facilitated nine startups during record-setting year

   05/12/2021 The  Center for Technology Transfer and Commercialization  continued to play a pivotal role ... rehabilitation. IDBiologics  discovers and develops human monoclonal antibodies for the prevention, treatment and cure of ...

   sommers - 05/26/2021 - 10:39am

7. Dr. James Crowe Jr. receives SEC Faculty Achievement Award

   ... on the front lines of global research to eliminate human susceptibility to COVID-19 and other illnesses, is Vanderbilt ... the pinnacle of higher education’s mission to improve the human condition, and we could not be more delighted to provide this ... cited papers in leading scientific journals, including  Cell ,  Science  and in major medical journals such as  NEJM  and  ...

   sommers - 04/12/2021 - 10:53am

8. New leadership announced for the Wond’ry

   ... engineering management,  Peabody College of education and human development  as professor of the practice of teaching and learning, and ... while working in close partnership with the  Center for Technology Transfer and Commercialization .” Companies where Owens has ...

   sommers - 06/12/2019 - 8:35am

9. Tech Connect, Vol. 7, Issue 12: Vanderbilt Inventor wins ASPET Award

   ... ASPET said Lindsley was honored for “his pioneering use of technology-enabled synthesis, which led to fundamental and transforming effects ... company regarding the use of a mouse model for chronic beta cell depolarization developed by Mark Magnuson of the Center for Stem Cell ...

   steelmk - 07/21/2017 - 3:09pm

10. Tech Connect, Vol. 7, Issue 5: New study shows Play Nicely™ program is an effective positive parenting strategy

    ... Technology Spotlight:  microRNAs Inhibition of Selected ... Pipeline The vaccine pipeline lists antigens and human monoclonal antibodies available for license for vaccine development ...

    steelmk - 11/15/2016 - 2:29pm